On Dec. 18, 2020, the National Research Council of Canada (NRC) announced it was providing advisory services and over $9 million in research and development funding to support 4 therapeutic firms, including: Bold Therapeutics, JN Nova Pharma, Laurent Pharmaceuticals and Qu Biologics.

These investments helped produce safe and effective treatments for those who contract the COVID-19 virus, while building domestic capabilities to fight future pandemics.